Quantinuum (NASDAQ:QNT) Shares Down 7.2% - What's Next?

Quantinuum logo with Technology background
Image from MarketBeat Media, LLC.

Key Points

  • Quantinuum shares fell 7.2% to $29.70 in Thursday midday trading, with volume 34% below its daily average.
  • Several analysts cut price targets, including Needham ($60), JPMorgan ($80), Bank of America ($50) and Cantor Fitzgerald ($55), but most maintained positive ratings. The consensus remains “Moderate Buy,” with an $80.21 target.
  • Quantinuum reported a quarterly loss of $0.29 per share, beating analysts’ expected $0.99 loss; revenue was $9.05 million.
  • Interested in Quantinuum? Here are five stocks we like better.

Quantinuum Inc. (NASDAQ:QNT - Get Free Report)'s stock price fell 7.2% during mid-day trading on Thursday. The company traded as low as $29.51 and last traded at $29.70. 1,549,987 shares were traded during trading, a decline of 34% from the average daily volume of 2,337,537 shares. The stock had previously closed at $31.99.

Analysts Set New Price Targets

Several brokerages recently commented on QNT. Needham & Company LLC cut their target price on Quantinuum from $100.00 to $60.00 and set a "buy" rating on the stock in a research report on Friday, November 6th. JPMorgan Chase & Co. lowered their price target on shares of Quantinuum from $97.00 to $80.00 and set an "overweight" rating for the company in a research report on Friday, November 6th. Bank of America decreased their price objective on Quantinuum from $85.00 to $50.00 and set a "buy" rating on the stock in a research note on Monday, November 9th. Rosenblatt Securities reaffirmed a "buy" rating and set a $155.00 target price on shares of Quantinuum in a research note on Thursday, October 22nd. Finally, Cantor Fitzgerald lowered their price objective on shares of Quantinuum from $90.00 to $55.00 and set an "overweight" rating for the company in a research note on Friday, November 6th. Fourteen analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, Quantinuum has a consensus rating of "Moderate Buy" and a consensus target price of $80.21.

Check Out Our Latest Stock Report on Quantinuum

Quantinuum Price Performance

The stock's 50 day simple moving average is $41.40. The stock has a market capitalization of $7.53 billion and a P/E ratio of -38.13.

Quantinuum (NASDAQ:QNT - Get Free Report) last posted its quarterly earnings data on Thursday, November 5th. The company reported ($0.29) EPS for the quarter, beating analysts' consensus estimates of ($0.99) by $0.70. The company had revenue of $9.05 million for the quarter. On average, analysts forecast that Quantinuum Inc. will post -3.70 earnings per share for the current fiscal year.

Institutional Trading of Quantinuum

A number of institutional investors have recently bought and sold shares of the business. Wellington Management Group LLP acquired a new stake in Quantinuum during the 2nd quarter worth approximately $92,418,000. Voya Investment Management LLC raised its holdings in shares of Quantinuum by 143.2% in the 3rd quarter. Voya Investment Management LLC now owns 1,681,316 shares of the company's stock valued at $80,804,000 after acquiring an additional 989,879 shares in the last quarter. State Street Corp purchased a new stake in Quantinuum during the third quarter valued at about $18,491,000. HBK Investments L P purchased a new position in shares of Quantinuum during the second quarter valued at approximately $14,669,000. Finally, BlueCrest Capital Management Ltd bought a new stake in shares of Quantinuum during the second quarter valued at approximately $14,304,000.

About Quantinuum

(Get Free Report)

Quantinuum develops quantum computers, software and cybersecurity products for businesses, researchers and government organizations. Its work includes trapped-ion quantum systems, tools for programming and managing quantum applications, and services focused on quantum chemistry and data security. The company was formed in 2021 through the combination of Honeywell Quantum Solutions and Cambridge Quantum, bringing together quantum hardware and software capabilities. Its offerings include the H-series quantum computers, the TKET software development kit and InQuanto, a platform for quantum chemistry research.

Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Quantinuum Right Now?

Before you consider Quantinuum, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Quantinuum wasn't on the list.

While Quantinuum currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines